Clinical Trial Update: Remaxol® in Malignant Mechanical Jaundice [Phase 3]

View source ↗

Summary

Phase 3 trial update for Remaxol in malignant jaundice has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Jaundice
• Malignant Jaundice

Drugs mentioned

• Remaxol

Snippet

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company | Conditions: Jaundice; Malignant | Phase 3 | Status: COMPLETED